About Teknova
Teknova is a publicly listed company based in Hollister (United States) founded in 1996. Molecular biology reagents and kits are supplied for research applications. The company has 173 employees. Its website teknova.com draws about 36 thousand monthly visits. Teknova offers products and services including AAV•Tek PCR Sample Prep Kit, Agar Plates, Buffers and Reagents, and Custom Manufacturing. Its focus areas include Life Sciences, Genomics, Enabling Technologies and Kits and Reagents. Its legal entity is Alpha Teknova, Inc. Its competitors include GenScript, OriGene and Meridian Bioscience; 2 of its 3 listed competitors have raised funding.
Company details
Teknova was founded in 1996 and is located in Hollister, United States. Molecular biology research reagents and kits are manufactured by the company for various scientific applications. Custom media, buffers, pre-poured agar plates, dry and liquid culture media, and supplements are produced to support processes including cloning, gene expression, DNA purification, PCR, and sequencing. Operations focus on the biotechnology sector, serving needs in immunology and molecular analysis.
- Headquarters Hollister, United States
- Employees 173
- Stage Public
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website teknova.com
- Social LinkedIn X Facebook
- Legal Name Alpha Teknova, Inc.
- Annual Revenue$40.52 M (USD)7.35as on Dec 31, 2025
- Net Profit-$17.26 M (USD)35.47as on Dec 31, 2025
- EBITDA-$9.63 M (USD)47.26as on Dec 31, 2025
- Latest Funding Round$20.9M (USD), Post-IPO
Sep 2023
- Investors
- Employee Count173
Products & Services of Teknova
Teknova offers a comprehensive portfolio of products and services, including AAV•Tek PCR Sample Prep Kit, Agar Plates, Buffers and Reagents, and Custom Manufacturing.
Kit for preparing PCR samples in gene therapy applications.
Plates for growing bacterial and fungal cultures.
Solutions for biochemical reactions and storage.
Tailored production of biotechnology reagents.
Funding Insights of Teknova
- Total Rounds 2
- Last Round Post-IPO — $20.9M
- First Round $325,790
(May 2016)
- Investors Count 1
All 2 funding rounds of Teknova with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2023 | $20.9M | Post-IPO | – | – | – |
| May 2016 | $325,790 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Teknova
Teknova has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Teknova
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Teknova
26 people are tracked at Teknova (11 in leadership, 6 in board & advisors, 9 in team); the tracked headcount is 173.
| Name | Role | Group |
|---|---|---|
Lisa McCann | Chief People Officer | Leadership |
Matthew Lowell | Chief Financial Officer | Leadership |
Stephen Gunstream | President & CEO | Leadership |
Ben Viering | VP, IS & Architecture | Leadership |
Rakesh A. | Vice President Of Quality & Regulatory | Leadership |
Calvin Mitchell | Director Of Information Technology | Leadership |
Bob Wright | Associate Director, Enterprise Software Development | Leadership |
Iris Delgado Alatorre | Director Of GMP Operations | Leadership |
Carl R. Brown | Senior Director, Fp&a And Operations Finance | Leadership |
Deserie Presley | Associate Director, People Operations | Leadership |
Neil Abhyankar | Vice President Of Sales | Leadership |
Ted Davis | Director | Board & advisors |
J. Matthew Mackowski | Director | Board & advisors |
Alexander Vos | Director | Board & advisors |
Brett Robertson | Director | Board & advisors |
Alexander Herzick | Director | Board & advisors |
Paul Grossman | Director | Board & advisors |
Logan West | Senior Commercial Operations Specialist | Team |
Jennifer Henry | SVP, Marketing | Team |
Damon Terrill | General Counsel & CCO | Team |
6 more people are available in the full profile.
Complete people profiles for Teknova
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Teknova
Teknova is a publicly listed company on the NASDAQ with ticker symbol TKNO in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date25 Jun 2021
- Listed onNASDAQ: TKNO
- Listed entityAlpha Teknova, Inc.
- Exchange sectorHealth technology
- ISINUS02080L1026
- Share price$8.22 (-5.52% on the day) · 2026-10-13
- Market capitalisation$441.3M
- EPS (diluted, trailing year)$-0.31
- Volume (last session)232,093
Financials of Teknova
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $40.5M | -$17.3M | -$9.6M |
| 2024 | $37.7M | -$26.8M | -$18.3M |
| 2023 | $36.7M | -$36.8M | -$24.8M |
| 2022 | $41.4M | -$47.5M | -$25.4M |
| 2021 | $36.9M | -$9.8M | -$9.1M |
Detailed financial statements for Teknova
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Teknova
4 dated milestones of Teknova across 27 years, from founding to its latest funding, stage changes and deals.
- Founded Teknova is founded.
- Funding First funding round of $326K.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Post-IPO, of $20.9M.
Competitors of Teknova
Teknova has 3 listed competitors in our database, 2 of them funded. They include GenScript, OriGene and Meridian Bioscience.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| genscript.com | 2002 | Piscataway, United States | $15M | 5,260 | Reagents and instruments are provided for life sciences research. | |
| origene.com | 1996 | Rockville, United States | $69.55M | 141 | Proteins, antibodies, and molecular tools are manufactured for research applications. | |
| meridianbioscience.com | 1976 | Ohio, United States | Molecular diagnostic device and kits |
Detailed competitors of Teknova
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Teknova
The website of Teknova (teknova.com) receives about 36.5K visits a month.
- Monthly visits36.5K
▲ 8.2% vs previous month
Websites whose visitors overlap most with Teknova. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
aniara.com | aniara.com | 100% | #2,362,029 | – | |
| ixcellsbiotech.com | 96% | 14.2K | #1,627,815 | View details | |
| bio-rad.com | 94% | 665.2K | #79,666 | View details | |
| scbt.com | 92% | 444.3K | #138,937 | View details | |
| biomyx.net | 90% | View details | |||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 35 similar websites and full traffic analytics for Teknova
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 35 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Teknova (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Teknova
Complete news archive for Teknova
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Teknova
Teknova was founded in 1996 and raised its 1st funding round 20 years after it was founded.
Teknova is headquartered in Hollister, United States. It is registered at Hollister, California, United States.
Teknova has 173 employees.
Annual revenue of Teknova is $40.52M as on Dec 31, 2025.
Teknova was founded in 1996 and is located in Hollister, United States. Molecular biology research reagents and kits are manufactured by the company for various scientific applications. Custom media, buffers, pre-poured agar plates, dry and liquid culture media, and supplements are produced to support processes including cloning, gene expression, DNA purification, PCR, and sequencing. Operations focus on the biotechnology sector, serving needs in immunology and molecular analysis.
Teknova's top competitors include Meridian Bioscience, GenScript and OriGene.
Teknova offers AAV•Tek PCR Sample Prep Kit, Agar Plates, Buffers and Reagents, and Custom Manufacturing.
Yes, Teknova is publicly traded on NASDAQ under the ticker symbol TKNO.
Teknova has 1 investor. Key investors include European Union.
Teknova operates through Alpha Teknova, Inc..